Tilray Launches New Latin America Subsidiary

- December 3rd, 2018

Tilray announced the acquisition of its import and distributor partner Alef Biotechnology SpA to re-brand it as Tilray Latin America SpA.

Tilray (NASDAQ:TLRY) announced the acquisition of its import and distributor partner Alef Biotechnology SpA to re-brand it as Tilray Latin America SpA.

As quoted in the press release:

Tilray Latin America will further strengthen Tilray’s position as a global leader in the medical cannabis market. Tilray currently has medical cannabis products available in twelve countries and operates globally through its wholly-owned subsidiaries in Australia [and] New Zealand, Canada, Germany, and Portugal.

Tilray Latin America will import, produce and distribute Tilray branded medical cannabis products in Chile and create a hub to distribute Tilray products throughout Latin America, subject to local laws.

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Leave a Reply

Your email address will not be published. Required fields are marked *